4ZG.F 3.88 (+2.37%)
FR0011049824Medical Diagnostics & ResearchDiagnostics & Research

Median Technologies (4ZG.F) Competitor Comparison

We are evaluating the key criteria listed to compare Median Technologies (4ZG.F) against its competitors in the Diagnostics & Research industry.

Performance 5 years - 4ZG.F ranking 0 / 58

These are the competitors of Median Technologies in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
523.01
2. Medpace Holdings MEDP
360.05
3. RadNet RDNT
355.92
4. Natera NTRA
220.75
5. Danaher DHR
125.2
6. Meridian Bioscience VIVO
118.46
7. Thermo Fisher Scientific TMO
114.09
8. Icon ICLR
110.54
9. Mettler-Toledo MTD
106.15
10. Twist Bioscience TWST
91.63
11. Agilent Technologies A
87.61
12. DexCom DXCM
86.16
13. Fulgent Genetics FLGT
73.64
14. IQVIA Holdings IQV
64.37
15. IDEXX Laboratories IDXX
62.06
16. Waters WAT
61.86
17. DarioHealth DRIO
61.4
18. Qiagen QGEN
51.62
19. PerkinElmer PKI
48.44
20. Charles River Laboratories CRL
48.14
21. Laboratory Corp of America Holdings LH
47.51
22. Quest Diagnostics DGX
42.75
23. Co-Diagnostics CODX
21.9
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. CareDx CDNA
-8.3
27. Bioventus BVS
-14.24
28. Syneos Health SYNH
-16.98
29. Anixa Biosciences ANIX
-18.65
30. Myriad Genetics MYGN
-22.55
31. Exact Sciences EXAS
-25.62
32. Olink Holding OLK
-26.82
33. NeoGenomics NEO
-33.1
34. Sotera Health SHC
-40.74
35. Sera Prognostics SERA
-48.9
36. Illumina ILMN
-51.76
37. Neogen NEOG
-56.13
38. Inotiv NOTV
-57.32
39. Trinity Biotech TRIB
-57.78
40. Personalis PSNL
-59.92
41. Pacific Biosciences of California PACB
-63.33
42. Interpace Biosciences IDXG
-63.8
43. National Research NRC
-64.2
44. Enzo Biochem ENZ
-64.29
45. Guardant Health GH
-68.16
46. Psychemedics PMD
-75.29
47. MaxCyte MXCT
-77.81
48. Exagen XGN
-78.44
49. bioAffinity Technologies BIAF
-83.21
50. MDxHealth MDXH
-83.54
51. Global Cord Blood CO
-86.47
52. Precipio PRPO
-86.51
53. Biodesix BDSX
-88.15
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.74

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.